Citigroup
ZBH icon

Citigroup’s Zimmer Biomet ZBH Stock Holding History

Citigroup’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-824
Closed -$123K – 7556
2020
Q4 		$123K Sell
824
-10,197
-93% -$1.44M ﹤0.01% 5376
2020
Q3 		$1.46M Sell
11,021
-7,519
-41% -$982K ﹤0.01% 2944
2020
Q2 		$2.15M Sell
18,540
-17,613
-49% -$2.03M ﹤0.01% 2735
2020
Q1 		$3.55M Buy
36,153
+32,960
+1,032% +$4.32M ﹤0.01% 1954
2019
Q4 		$464K Sell
3,193
-9,579
-75% -$1.32M ﹤0.01% 4482
2019
Q3 		$1.7M Sell
12,772
-11,227
-47% -$1.45M ﹤0.01% 3038
2019
Q2 		$2.74M Sell
23,999
-51,706
-68% -$6.06M ﹤0.01% 2518
2019
Q1 		$9.39M Sell
75,705
-7,210
-9% -$819K 0.01% 1310
2018
Q4 		$8.35M Buy
82,915
+53,354
+180% +$6M 0.01% 1395
2018
Q3 		$3.77M Buy
29,561
+20,188
+215% +$2.4M ﹤0.01% 2145
2018
Q2 		$1.01M Sell
9,373
-26,574
-74% -$2.89M ﹤0.01% 3349
2018
Q1 		$3.81M Buy
35,947
+21,733
+153% +$2.52M ﹤0.01% 2021
2017
Q4 		$1.67M Buy
14,214
+8,034
+130% +$908K ﹤0.01% 2856
2017
Q3 		$703K Buy
6,180
+4,223
+216% +$487K ﹤0.01% 3742
2017
Q2 		$244K Sell
1,957
-11,124
-85% -$1.32M ﹤0.01% 4630
2017
Q1 		$1.55M Sell
13,081
-22,042
-63% -$2.5M ﹤0.01% 2728
2016
Q4 		$3.52M Buy
35,123
+33,578
+2,173% +$3.6M ﹤0.01% 2247
2016
Q3 		$195K Buy
+1,545
New +$191K ﹤0.01% 4680
2014
Q1 		– Sell
-5,150
Closed -$466K – 7234
2013
Q4 		$466K Sell
5,150
-19,570
-79% -$1.69M ﹤0.01% 3855
2013
Q3 		$1.97M Buy
24,720
+8,343
+51% +$657K ﹤0.01% 2461
2013
Q2 		$1.19M Buy
+16,377
New +$1.22M ﹤0.01% 2751

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's ZBH Position: Q1 2026 in Review

Citigroup reduced its Zimmer Biomet (ZBH) stake by 3.2% in Q1 2026, selling an estimated $582K and leaving 194,382 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1141.

Citigroup first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $76.6M in Q1 2021. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Citigroup held 194,382 shares of Zimmer Biomet worth $17.6M as of Q1 2026.
  • Citigroup sold 6,346 Zimmer Biomet shares in Q1 2026, an estimated $582K.
  • Zimmer Biomet made up 0.01% of Citigroup's portfolio in Q1 2026, its #1141 holding.
  • Citigroup first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Zimmer Biomet position peaked at $76.6M in Q1 2021.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.